Changing the way people view cannabis.

PharmaCann, founded in 2014, is one of the country’s largest vertically integrated cannabis companies, providing safe, reliable, top-quality cannabis products to improve people’s lives. By investing in people, practices, and infrastructure, we are shaping a new, vital, wellness-focused industry. Our goal is to increase sustainable access to cannabis by offering effective, affordable and trusted products and services.

We are licensed in eight states to grow, process and/or dispense medical cannabis products for adult and pediatric patients, as well as for responsible adult use. We are expanding rapidly as we continue to earn new state licenses and gain recognition as a trusted resource in this evolving space.

Our dispensaries operate under the brand Verilife and are designed to help people feel better and get more enjoyment out of life by becoming comfortable with the safe, informed use of quality cannabis.

We invest in best practices at every turn to ensure people have access to the most effective options for feeling and living better. We are constantly researching and developing new forms and formulations of cannabinoid-based treatments to improve people’s well-being.

Mission & Vision

PharmaCann’s mission is to lead the cannabis industry with respect to the quality of its employees, facilities, products and research and development efforts to discover the true scientific benefits of cannabis.

PharmaCann’s vision is to improve the quality of life for people through discovery, production and responsible dispensing of cannabis-related products. PharmaCann seeks to lead in the science-based understanding of the full impact of cannabis for the healthcare and wellness industries.

Locations

Click on the state below to learn more about our footprint and facilities.

Highlights

  • Awarded 6 Illinois licenses—the most in the state at time of award
  • Serving nearly 80 percent of the Chicagoland market
  • One of only 20 large scale cultivators awarded a license for upcoming adult-use
    Co-site retail locations for medical and adult-use (January 2020)

Facilities:

Dispensaries

Production

Highlights

  • Located in Montgomery County (most populated county in Maryland)
  • Offers a wide variety of cannabis products from multiple cultivators

Facilities:

Dispensaries

Highlights

  • One of the first 5 dispensaries in the state to be pre-approved for adult use
  • Only dispensary serving the Cape Cod area within 25 miles

Facilities:

Dispensaries

Highlights

  • 127,572 square foot state-of-the-art production facility
  • Same day delivery service available for our Bronx patients, two-day delivery available through our other locations

Facilities:

Dispensaries

Production

Highlights

  • First dispensary to open in Cincinnati proper
  • Flagship marijuana dispensary
  • Custom built, free-standing flagship dispensary

Facilities:

Dispensaries

 

Highlights

  • One of the first dispensaries to open in Philadelphia proper
  • First dispensary to open in Manayunk neighborhood

Facilities:

Dispensaries

 

Team

Trusted. Professional. Expert.

We are devoted to helping people live their best lives. With a wide range of backgrounds in areas such as business, law, finance, accounting, horticulture, engineering, research, healthcare and retail, our team is well-suited to meet the challenges of a rapidly evolving industry. With our blue-chip leadership and talented team members, PharmaCann has become known as a national thought leader and respected research partner in the cannabis industry.

Brett Novey

Brett Novey

Chief Financial Officer

Brett has more than 15 years of experience across multiple disciplines including corporate finance and restructuring. Prior to joining PharmaCann, Brett was the Head of Financial Planning & Analysis for KCG Holdings, Inc., where he was responsible for cash/capital management, monthly forecasting and the annual budgeting process. Prior to KCG, Brett worked for Sears Holdings, KPMG and Arthur Andersen. He holds a Bachelor’s degree in accounting and finance from Indiana University, and a Master’s from Northwestern’s Kellogg School of Management.

Brett Novey

 Chief Executive Officer

Teddy Scott

Teddy Scott

Chief Executive Officer & Founder

Teddy Scott co-founded PharmaCann in 2014. Prior to PharmaCann, he was an equity partner at Polsinelli PC, an American Lawyer Top-100 law firm representing pharmaceutical and biotech companies in the development and commercialization of FDA-approved therapies. Teddy is also a co-founder of Accelerated Pharma, Inc., a pharmaceutical company based on rediscovery, repurposing and relaunching previously unsuccessful drug candidates and serves as outside counsel and advisor for MATTER, a med-tech startup incubator in Illinois. He is also on the board of advisors for the University of Chicago Innovation Fund. Teddy earned his Ph.D. in molecular biophysics from University of Texas Southwestern Medical Center at Dallas and his J.D. from Northwestern University School of Law.

Teddy Scott, Ph.D.

Founder & Board Member

Stephen Schuler

Stephen Schuler

Board Member

Stephen Schuler, a serial entrepreneur, co-founded GETCO LLC, one of the first and most successful electronic trading firms. In 2013, GETCO acquired Knight Capital Group and created the publicly traded company KCG Holdings, Inc. Stephen is a former Director at KCG and current Director at Wicklow Capital, which focuses on early-stage to pre-IPO investment opportunities.

Stephen Schuler

Board Member

Greg Cappelli

Greg Cappelli

Executive Director

PharmaCann’s newest executive director, Greg served as the fourth Chief Executive Officer of Apollo Education Group from 2009 to 2017. Before joining Apollo Education Group in 2007, he spent over a decade as a managing director for Credit Suisse, where he served as a senior research analyst and founded the Credit Suisse Global Services Group. In 2016, Greg successfully helped organize and execute on a plan to take AEG private and establish new ownership under Apollo Global Management and The Vistria Group. Greg is the founder and current executive chairman of Apollo Global—now Vanta Educational Group. He’s a regular speaker at industry conferences on various topics including higher education and workforce development. He has conducted over 400 meetings with members of the United States Congress, Department of Education and the White House to discuss and help shape education and workforce development policy in the U.S., and continues to have an active dialogue with various governments around the world.

Greg Cappelli

Executive Director

Dan Roth

Dan Roth

Chief Financial Officer

Daniel has more than 20 years of experience in accounting and finance roles. Prior to joining PharmaCann, Daniel was the Corporate Controller of KCG Holdings, Inc. (formerly Knight Capital Group, Inc.), where he was responsible for overseeing the Company’s books and records, consolidations, SEC reporting, management reporting and accounting for various corporate transactions. Prior to KCG, Daniel worked for PricewaterhouseCoopers, specializing in audits and corporate transactions within the financial services industry. Daniel is a Certified Public Accountant and holds a Bachelor’s degree in accounting from Indiana University and a Masters of Business Administration from New York University’s Stern School of Business.

Dan Roth

Chief Financial Officer

Mike Chodil

Mike Chodil

Chief Strategy Officer

Mike heads up strategic services and all operations functions on an interim basis for the Midwest region, from manufacturing to processing to retail. He has more than 20 years of experience in business management, operations and finance. Before joining PharmaCann, Mike worked at KCG Holdings/GETCO, Hewitt Associates and Comdisco where he focused on cost and data management, financial planning and analysis, risk management and sales operations. Mike earned his Bachelor’s degree in biomedical engineering from the University of Iowa and his Master’s in finance and accounting from University of Illinois at Chicago.

Mike Chodil

Chief Strategy Officer

Robert McQueen

Robert McQueen

General Counsel

Robert is a veteran in advising publicly traded and privately owned companies, spanning a broad range of practice areas, including corporate and securities law, mergers, acquisitions and divestitures, debt financing, corporate governance, strategic investments, corporate compliance and investor relations. Prior to joining PharmaCann, Robert served as deputy general counsel at KCG (formerly GETCO), and he began his career as an attorney in the corporate groups of Fried, Frank, Harris, Shriver & Jacobson LLP and Katten Muchin Rosenman LLP. Robert holds a B.B.A. from Emory University’s Goizueta Business School and a J.D. from Boston College Law School.

Robert McQueen

General Counsel

Sue Mullin

Sue Mullin

Chief Human Resources Officer

Sue brings more than 25 years of senior HR leadership experience in Global Fortune 2000 information services, consulting and manufacturing. Prior to joining PharmaCann, Sue worked at organizations such as Wolters Kluwer, CCH Incorporated and Northrop Grumman. She brings extensive experience in developing performance management programs, designing organizational structures, directing talent acquisition, executive coaching, change management, employee relations and compensation management. Sue studied English at Roosevelt University and holds CCP and SPHR designations.

Sue Mullin

Chief Human Resources Officer

Current Openings

View Open Positions

Contact

Please contact us to learn more about PharmaCann.

190 South LaSalle
Chicago, IL 60603
Phone: 888-493-6066

HQ

190 South LaSalle, Chicago, IL 60603